title: Management and rehabilitation of neurologic patients with sexual dysfunction.
abstract: Neurologic disease frequently negatively affects sexual experience in multiple ways. The patient's sexual self-image, sexual function, propensity to sexual pain, and motivation to be sexually active may be impacted, as may the sexual experiences of the partner. Difficulties with mobility can limit both partners' sexual arousal and pleasure. Conditions associated with chronic pain or continence concerns add further distress. Thus sexual rehabilitation needs to address many areas. Comorbid depression is common and needs to be stabilized before definitive treatment of sexual dysfunction. Management strategies include cognitive behavioral therapy, mindfulness-based cognitive therapy, and sex therapy and, for erectile dysfunction and premature ejaculation, pharmacotherapy can be added. Benefit from all these modalities is confirmed in the general population but only pharmacologic treatment of erectile dysfunction has been studied in neurologic patients, where benefit is also seen. Testosterone is indicated only for comorbid testosterone deficit: very occasionally the neurologic condition causes secondary male hypogonadism. No androgen deficiency state has been identified in women. Results of testosterone treatment in women are conflicting: recruited women were not clearly dysfunctional and women with neurologic conditions have not been studied. Future research involving both partners using combined medical and psychologic therapy as followed in clinical practice is advocated.
authors.affiliation: Department of Psychiatry, University of British Columbia, Vancouver, Canada. Electronic address: rosemary.basson@vch.ca.
authors.forename: Rosemary
authors.initials: R
authors.lastname: Basson
authors.affiliation: Sexual Medicine Center, Department of Urology, Sheba Medical Center, Tel-Hashomer, Israel.
authors.forename: Gila
authors.initials: G
authors.lastname: Bronner
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D009422:Nervous System Diseases / Q000150:complications* / Q000628:therapy*; D012735:Sexual Dysfunction, Physiological / Q000209:etiology* / Q000628:therapy*
keywords: cognitive therapies; neurologic sexual dysfunction; phosphodiesterase inhibitors; sex therapy